In September, scientists reported promising results from a clinical study treating patients suffering from Ataxia Telangiectasia (AT) with NAD boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). For those unfamiliar, according to the Cleveland Clinic, “Ataxia is the term for a group of neurological diseases (diseases related to the nervous system) that affect movement and coordination”. Last week, the folks at NR seller Chromadex discussed the clinical findings during their latest earnings call:
